{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:01:27Z","timestamp":1780380087460,"version":"3.54.1"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p>OBJETIVO: Identificar fatores de risco para a recidiva da tuberculose. M\u00c9TODOS: Estudou-se uma coorte de 610 pacientes com tuberculose pulmonar bacil\u00edfera inscritos para tratamento entre 1989 e 1994 e curados com o esquema contendo rifampicina, isoniazida e pirazinamida (RHZ). Avaliaram-se os seguintes fatores de risco: idade, sexo, cor, dura\u00e7\u00e3o dos sintomas, cavita\u00e7\u00e3o das les\u00f5es, extens\u00e3o da doen\u00e7a, diabetes melito, alcoolismo, infec\u00e7\u00e3o pelo HIV, negativa\u00e7\u00e3o tardia do escarro, ades\u00e3o ao tratamento e doses dos f\u00e1rmacos. Para detec\u00e7\u00e3o das recidivas, os pacientes foram seguidos por 7,7 \u00b1 2,0 anos, ap\u00f3s a cura, pelo sistema de informa\u00e7\u00e3o da Secretaria Estadual da Sa\u00fade do Rio Grande do Sul. Nas an\u00e1lises utilizaram-se os testes t de Student, qui-quadrado ou exato de Fisher e a regress\u00e3o de Cox. RESULTADOS: Ocorreram 26 recidivas (4,3%), correspondendo a 0,55\/100 pessoas-ano. A taxa de recidiva foi de 5,95 e 0,48\/100 pessoas-ano, respectivamente, nos pacientes HIV-positivos e nos HIV-negativos (p &lt; 0,0001). Na an\u00e1lise multivariada, a infec\u00e7\u00e3o pelo HIV [RR = 8,04 (IC95%: 2,35-27,50); p = 0,001] e o uso irregular da medica\u00e7\u00e3o [RR = 6,43 (IC95%: 2,02-20,44); p = 0,002] mostraram-se independentemente associados \u00e0s recidivas. CONCLUS\u00d5ES: A recidiva da tuberculose foi mais freq\u00fcente nos pacientes HIV-positivos e naqueles que n\u00e3o aderiram ao tratamento auto-administrado (esquema-RHZ). Pacientes com pelo menos um destes fatores de risco poder\u00e3o se beneficiar com a implanta\u00e7\u00e3o de um sistema de vigil\u00e2ncia p\u00f3s-tratamento para detec\u00e7\u00e3o precoce de recidivas. Para prevenir a n\u00e3o-ades\u00e3o ao tratamento da tuberculose, a alternativa seria a utiliza\u00e7\u00e3o de tratamento supervisionado.<\/jats:p>","DOI":"10.1590\/s1806-37132007000500013","type":"journal-article","created":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T05:19:35Z","timestamp":1195276775000},"page":"572-578","source":"Crossref","is-referenced-by-count":24,"title":["Fatores de risco para a recidiva da tuberculose"],"prefix":"10.1590","volume":"33","author":[{"given":"Pedro Dornelles","family":"Picon","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Luiz","family":"Bassanesi","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza Avancini","family":"Caramori","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Luiz Targa","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Secretaria Estadual a Sa\u00fade do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Adriane","family":"Jarczewski","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Rodrigues de Borba","family":"Vieira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-76-3-112-6-397","article-title":"USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results","volume":"112","author":"Combs DL","year":"1990","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1164\/ajrccm\/144.4.750","article-title":"Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with \"standard\" chemotherapy in Kinshasa, Zaire","volume":"144","author":"Perri\u00ebns JH","year":"1991","journal-title":"Am Rev Respir Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0003-0805","issn-type":"print"},{"issue":"8867","key":"ref3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0140-6736(93)91474-Z","article-title":"Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya","volume":"342","author":"Hawken M","year":"1993","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"5","key":"ref4","first-page":"455","article-title":"The impact of HIV infection on recurrence of tuberculosis in South African gold miners","volume":"4","author":"Mallory KF","year":"2000","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"9240","key":"ref5","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial","volume":"356","author":"Fitzgerald DW","year":"2000","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/323784","article-title":"Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City","volume":"33","author":"Driver CR","year":"2001","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/375220","article-title":"Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review","volume":"37","author":"Korenromp EL","year":"2003","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJM199503233321204","article-title":"Pulmonary tuberculosis in HIV-infected patients in Zaire: A controlled trial of treatment for either 6 or 12 months","volume":"332","author":"Perri\u00ebns JH","year":"1995","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/00002030-199908200-00015","article-title":"Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa","volume":"13","author":"Connolly C","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"14","key":"ref10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/00002030-199910010-00012","article-title":"Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons","volume":"13","author":"Sterling TR","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1164\/ajrccm.154.4.8887603","article-title":"Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection","volume":"154","author":"Chaisson RE","year":"1996","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"9294","key":"ref12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers","volume":"358","author":"Sonnenberg P","year":"2001","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1473-3099(03)00607-8","article-title":"Recurrence in tuberculosis: relapse or reinfection?","volume":"3","author":"Lambert ML","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"Verver S","year":"2005","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"key":"ref15"},{"issue":"2","key":"ref16","first-page":"145","article-title":"Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area","volume":"7","author":"de Boer AS","year":"2003","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"7","key":"ref17","first-page":"631","article-title":"Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?","volume":"7","author":"Quy HT","year":"2003","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"5","key":"ref18","first-page":"556","article-title":"Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India","volume":"9","author":"Thomas A","year":"2005","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"key":"ref19","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"1171","volume-title":"Drugs Used in the Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy","author":"Petri Jr WA","year":"2001"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.111.5.1168","article-title":"Noncompliance with directly observed therapy for tuberculosis: Epidemiology and effect on the outcome of treatment","volume":"111","author":"Burman WJ","year":"1997","journal-title":"Chest","ISSN":"https:\/\/id.crossref.org\/issn\/0012-3692","issn-type":"print"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archinte.1997.00440230105014","article-title":"Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients","volume":"157","author":"Pulido F","year":"1997","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"issue":"1","key":"ref22","first-page":"39","article-title":"Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala","volume":"10","author":"Okwera A","year":"2006","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/381675","article-title":"Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use","volume":"38","author":"Nettles RE","year":"2004","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"9323","key":"ref24","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri M","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"Seyler C","year":"2005","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"13","key":"ref26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi E","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes G","year":"2002","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.2512002","article-title":"Update in tuberculosis 2005","volume":"173","author":"Yew WW","year":"2006","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"12","key":"ref29","first-page":"1385","article-title":"Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients","volume":"9","author":"Lopez-Cortes LF","year":"2005","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"22","key":"ref30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","article-title":"Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study","volume":"293","author":"Grant AD","year":"2005","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v33n5\/v33n5a13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T21:37:37Z","timestamp":1495748257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132007000500013&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1806-37132007000500013"],"URL":"https:\/\/doi.org\/10.1590\/s1806-37132007000500013","relation":{},"ISSN":["1806-3713"],"issn-type":[{"value":"1806-3713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}